Introduction

F-FDG-PET and
99m Tc-ECD-SPECT highlight the different distribution of pathology in dementing disorders and neurological diseases, thus aiding diagnosis. It is of note that functional neuroimaging with SPECT and PET predicts the risk of progression to probable Alzheimer Diseases (AD) dementia in Mild Cognitive Impairment (MCI) subjects.
1,2
Statistical Parametric Mapping (SPM) is an analysis tool for the in-vivo assessment of brain functional parameters.
3 It is a voxel-based methodology that can take a group of SPECT, PET or other functional measurements and generate spatial maps of statistically significant hypo/hyper functionality in cerebral regions. A common application of this method in the neurology and nuclear medicine communities includes the assessment of patient populations with respect to normal control subjects. 4 The voxel-based assessments of changes in the functional signal allow earlier and better diagnosis of neurological pathologies also less biased than qualitative visual inspection of images or quantitative region-of-interest analysis. 5, 6 Although the SPM software is freely-available (http:// www.fil.ion.ucl.ac.uk/spm/software/) and widely used all over the world, the use of the SPM software is limited by two constraints: 1) the availability of a substantial number of control SPECT/PET studies suitable for statistical comparison with patients (control studies representing several conditions of normalities to be compared with the patient on a single-subject basis), and 2) the use of a computational platform equipped with a MATLAB (www. mathworks.com), a specific commercial software package. The first requirement is complex due to ethical issues related to individual subject data and to the costs of storing and sharing a large set of in-vivo neuroimaging studies; the second requirement implies additional analysis costs, and potential performance limitations of the image analysis algorithms incurred due to the use of the commercial interpreter.
The aim of this work is to provide the expert medical community with a web-based service devoted to the use of SPM in the assessment of emission tomography neuroimages that will be ideal with respect to both: 1) the access to distributed databases of controls, property of the hospitals/centres in which they are collected but to be used by any service user, and 2) easy access to a highperformance computational system with the necessary requirements for the SPM statistical analysis. This goal was accomplished by the implementation of an open-toauthorized user, Grid-based web SPM service including: a) remote file access to Grid-distributed databases of SPECT and PET images of normal subjects numerically appropriate for statistical analysis, and b) a non commercial, free, Grid-distributed SPM version tailored for the analysis of brain images in neurological diseases (GriSPM).
Materials and Methods
GriSPM
A Grid data approach ("move code rather than data") was considered and used for the implementation of the proposed SPM software in order to: 1) keep clinical data in the proprietary hospitals/centres (forcing applications to access patient data) and 2) access to distributed computational resources. GriSPM is implemented on a platform based on gLite 3.1, the official Grid middleware for the European Grid infrastructure.
The functional architecture of GriSPM is described in Fig. 1. 1. The User can register and access the GriSPM through a web-browser. 2. A Grid Management Node (a web server with Grid middleware, GMN) provides User Authorization and Service Certification procedures (Authorization by verification of specific requisites, e.g. having attended proper GriSPM training courses; X509 Service Certification by MyProxy delegation mechanism). 3. The Authorized User (log in, password) at the User Node uploads to GMN the SPECT/PET images of patients to be evaluated. Files are anonymized and archived on the GMN into a User-accessible directory. With User permission, patient files are stored into a database of pathological subjects with neurological diseases (Patient database) for further follow-up evaluation. 4. The Authorized User accepts or modifies image preprocessing (SPM normalization and smoothing) parameters. Pre-processing parameters are sent to GMN. 5. GMN runs a patient pre-processing procedure and creates pre-processed patient images. 6. The Authorized User at the User Node, through the browser, selects a number of normal images suitable for the comparison of interest. 7. A query for normal images is sent from GMN to distributed Grid Repository Nodes (GRN, e.g. registry of different hospitals proprietary repository of normal images). 8. The software for the computation of the statistical analysis is sent, with a Grid job submission, from GMN to different Grid Worker Nodes (GWN, Computers with Grid middleware). 9. GWN compute the statistical data needed for the SPM analysis by reading (no copying) the User-selected normal images. 10. GWN returns statistical information to GMN. 11. GMN runs the SPM analysis using statistical information and produces the SPM results. 12. The Authorized User downloads the results of the SPM analysis at the User Node through the browser.
The GRID-distributed Database of Normal Subjects A Grid distributed database was configured providing access to SPECT/PET images of normal subjects on different hospitals/centres selected as GRN. Currently, two databases of normal images (one of SPECT images, and one for PET images) provided by the Nuclear Medicine Department of San Raffaele Hospital, Milan, Italy are available on the GRN of Department of Informatics, Systemistics and Telematics-Genoa University. Nineteen volunteers (10 males, 9 females, 21-75 years) and twentyone volunteers (11 males, 10 females, 21-74 years) were recruited for SPECT and PET, respectively. Volunteers were cognitively evaluated by experts using neuropsychological tests. All subjects gave their informed consent to participate to the studies.
SPECT Database of Normal Subjects
SPECT subjects underwent a Millenium VG SPECT (General Electric) scan of 25 min, 30 min after the injection of 99m
Tc-ECD (0.4 mCi/kg of patient weight) as required by conventional neurological acquisition protocol. SPECT acquisition parameters included: LEHR collimator, 20 cm rotation range, 120 projections, 128 × 128 acquisition matrix. SPECT images were reconstructed by a Filtered Backprojection algorithm (zoom: 1.5), filter xy, z: Butterworth (0.5-10) into an image volume of 128×128× (max 70) voxels, 2.94×2.94×2 mm 3 pixel size.
PET Database of Normal Subjects
PET subjects underwent a 3D PET Discovery LS (General Electric) scan of 15 min, 45 min after the injection of 
Validation of GriSPM
Validation of GriSPM Service
The GriSPM service was validated by two physicians and one physicist with SPM expertise at the Nuclear Medicine Department (User Site). Evaluators had access to the web site and tested the performance of GriSPM service in terms of 'ease of use' and quality of results (score: 1: low, 2: medium, 3: high).
Validation of GriSPM Software
GriSPM software was validated by comparing the results of the original SPM and of GriSPM on ten neurological patients.
Ten 99m Tc-ECD SPECT (5 males, 5 females, 61-82 years) and ten 18 F-FDG PET neurological patients (5 males, 5 females, 64-76 years) were studied following the same Fig. 1 The functional architecture of GriSPM protocol as for normal subjects. Images were analysed by original SPM and GriSPM as follows: Different p values (0.001<p<0.010), and different voxel cluster extensions v (1<v<70) were considered, for both reductions (hypo) and increases (hyper) of cerebral functions in the comparison studies.
Users tested the consistency of the two methods by visually comparing the resulting statistical maps. The statistical result maps were also statistically compared (X 2 test). 
Results
GriSPM
The GriSPM service is published and usable on the Internet web site www.neuroinf.it (User "Doctor", Section "Statistical analysis of SPECT and PET images").
7,8 A demonstration version of GriSPM service is available on the web site.
The GRID-distributed Database of Normal Subjects
The Grid-based databases of both SPECT and PET images of normal subjects are published and usable by Authorized Users on the web site www.neuroinf.it (Section "Statistical analysis of SPECT and PET images").
Validation GriSPM
Validation of GriSPM Service
All users gave the maximum scores (3) to GriSPM service for 'ease of use' and quality of results.
Validation of GriSPM Software
The results of the statistical comparisons between original SPM and GriSPM maps, in terms of X 2 values (normalized to the number of sample distributions), proved an excellent agreement for all patients, both for SPECT and PET (X 2 >0.99). Visual inspection of all SPM results confirmed the agreement. Evaluators agreed on the consistency of the two methods in showing comparable statistical t maps in each patient.
Representative examples of such an agreement are presented in Figs 
Discussion and Conclusions
The aim of this work was to make a service for the SPM analysis of SPECT and PET images of neurological patients available to the nuclear medicine and neurology community without the need of control studies and commercial software. The service was implemented on web, using Grid middleware, and provides: access to normative data deposited on Grid distributed nodes (hospitals proprietary of control images); and distributed processing of the analysis jobs on Grid nodes without moving proprietary image data on the net. This approach optimises performances of computational algorithms as well as satisfies security and property issues required by clinical data.
The Grid-distributed database will be enriched in the future with other control data from other partner hospitals/centres but also with pathological subjects (Patient Database). The GriSPM service has the potential to collect a large number of SPECT/PET images of neurological patients, which would allow prospective evaluation based on statistical comparisons between pathological groups (e.g. MCI vs. Alzheimer).
Clinicians particularly need a practical method to accurately differentiate different types of dementia. Visual interpretation of SPM maps after proper training (pre-requisite for a GriSPM Authorized use) could be more reliable and accurate in distinguishing between different dementia conditions than clinical methods alone, as shown in a post mortem confirmation study.
6
SPECT/PET SPM voxel-based studies might add important information that appropriately increases diagnostic confidence, even among experienced dementia specialists.
Information Sharing Statement
The software and datasets presented in this work can be accessed by Authorized Users at www.neuroinf.it (Sections "Statistical analysis of SPECT and PET images" and "Authorization") (not to be downloaded).
